P
Paul G. Richardson
Researcher at Harvard University
Publications - 1631
Citations - 174221
Paul G. Richardson is an academic researcher from Harvard University. The author has contributed to research in topics: Multiple myeloma & Bortezomib. The author has an hindex of 183, co-authored 1533 publications receiving 155912 citations. Previous affiliations of Paul G. Richardson include Broomfield Hospital & Dartmouth College.
Papers
More filters
Journal ArticleDOI
Consensus Report by Pediatric Acute Lung Injury and Sepsis Investigators and Pediatric Blood and Marrow Transplantation Consortium Joint Working Committees: Supportive Care Guidelines for Management of Veno-Occlusive Disease in Children and Adolescents, Part 1: Focus on Investigations, Prophylaxis, and Specific Treatment
Rajinder P.S. Bajwa,Kris M. Mahadeo,Benjamin H. Taragin,Christopher C. Dvorak,Jennifer McArthur,Asumthia Jeyapalan,Christine Duncan,Robert F. Tamburro,Alison Gehred,Leslie Lehmann,Paul G. Richardson,Jeffery J. Auletta,Ann E. Woolfrey +12 more
TL;DR: The joint working committees of the Pediatric Acute Lung Injury and Sepsis Investigators and thePediatric Blood and Marrow Transplantation Consortium collaborated to develop a series of evidence-based supportive care guidelines for management of VOD.
Journal ArticleDOI
An inhibitor of proteasome β2 sites sensitizes myeloma cells to immunoproteasome inhibitors.
Sondra L. Downey-Kopyscinski,Sondra L. Downey-Kopyscinski,Ellen W. Daily,Marc Gautier,Ananta Bhatt,Bogdan I. Florea,Constantine S. Mitsiades,Paul G. Richardson,Christoph Driessen,Herman S. Overkleeft,Alexei F. Kisselev,Alexei F. Kisselev +11 more
TL;DR: It is reported here that pharmacologically relevant concentrations of β5i-specific inhibitor ONX-0914 show cytotoxicity in MM cell lines similar to that of carfilzomib and bortezomib, and synergizes with all FDA-approved proteasome inhibitors in MM in vitro and in vivo.
Journal ArticleDOI
Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws
Nathaniel S. Treister,Nathaniel S. Treister,Paul G. Richardson,Robert L. Schlossman,Kenneth R. Miller,Kenneth R. Miller,Sook-Bin Woo,Sook-Bin Woo +7 more
TL;DR: Oral health care specialists and physicians must be alert to this potential complication of BONJ because it is easily managed with conservative measures and results in rapid and significant improvement in symptoms and overall quality of life.
Journal ArticleDOI
Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa
Kenneth Kintu,Philip Andrew,Philippa Musoke,Paul G. Richardson,Brenda Asiimwe-Kateera,Teopista Nakyanzi,Lei Wang,Mary Glenn Fowler,Lynda Emel,San San Ou,Lynn Baglyos,Sanjay Gurunathan,Sheryl Zwerski,J. B. Jackson,Laura Guay +14 more
TL;DR: The safety and feasibility results from phase 1 randomized double-blind placebo-controlled trial of ALVAC-HIV vCP1521 in infants born to HIV type 1-infected women in Uganda are reported in this paper.
Journal ArticleDOI
Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older.
Anays Murillo,Angel M. Cronin,Jacob P. Laubach,Tammy T. Hshieh,Anna M. Tanasijevic,Paul G. Richardson,Jane A. Driver,Gregory A. Abel +7 more
TL;DR: The results suggest that using age as a criterion to identify frailty in older patients with multiple myeloma may limit treatment options for the functionally vigorous.